Enorsua, Marivic V.
HRN: 21-61-25 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2022
CEFUROXIME 1.5GM (VIAL)
06/26/2022
07/03/2022
IV
1.5g
Q8H
AP
Waiting Final Action
06/26/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/26/2022
07/03/2022
IV
500mg
Q8H
AP
Waiting Final Action